文献速递传染病防控与疫情报告卫生政策与健康促进

南非豪登省SARS-CoV-2感染率与病死风险的估计:一项基于人群的血清流行病学调查

Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
PubMed 文献 · Int J Epidemiol · 2022-01-01

RBD IgG血清阳性率为19.1%(95%CI:18.1-20.1%),估算感染数289万余例,为报告病例的7.8倍;基于报告死亡(8198例)的感染病死率为0.28%(95%CI:0.27-0.30),基于超额死亡归因(21582例)则为0.67%(95%CI:0.64-0.71)。

要点

  • RBD IgG血清阳性率19.1%,儿童与成人相似,各分区介于5.5%至43.2%
  • 估算SARS-CoV-2感染数为报告COVID-19病例的7.8倍
  • 感染病死率按报告死亡计为0.28%,按超额死亡归因计为0.67%

核心结论

  • 估算SARS-CoV-2感染数为记录COVID-19病例的7.8倍
  • 按报告COVID-19死亡计算的感染病死率0.28%与按超额死亡归因计算的0.67%相差2.39倍
  • RBD IgG衰减可能低估感染数并高估死亡风险
  • 未来COVID-19波次的 epidemic 准备与应对规划需考虑真实感染规模,密切关注超额死亡趋势而非绝对报告COVID-19死亡

研究设计与样本

  • 采用三阶段随机家庭抽样,选样概率与分区规模成比例,按住房类型分层后从选定集群抽取家庭
  • 调查于2020年11月4日开始(第一波结束后8周,第一波SARS-CoV-2核酸扩增检测阳性率已降至<10%),与第二波高峰重合;最后采样于2021年1月22日(SARS-CoV-2复燃后9周)
  • 采用Luminex平台定量检测血清SARS-CoV-2受体结合域(RBD)免疫球蛋白G(IgG)
  • 共纳入3453户家庭中的6332人

主要发现

  • 总体RBD IgG血清阳性率为19.1%(95%CI:18.1-20.1%),儿童与成人相似
  • 各分区血清阳性率介于5.5%至43.2%
  • 保守估算截至2021年1月9日有2 897 120例(95%CI:2 743 907-3 056 866)SARS-CoV-2感染,感染率为每10万人19 090例,当时记录COVID-19病例330 336例
  • 基于记录COVID-19死亡(n=8198)的感染病死率为0.28%(95%CI:0.27-0.30)
  • 假设模型自然超额死亡中90%归因于COVID-19(n=21 582),感染病死率为0.67%(95%CI:0.64-0.71)

临床怎么用

  • epidemic 准备与应对规划需考虑真实感染规模,密切关注超额死亡趋势而非绝对报告COVID-19死亡

局限性

  • RBD IgG可能衰减,从而无意中低估SARS-CoV-2感染数并高估死亡风险

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limitations in laboratory testing capacity undermine the ability to quantify the overall burden of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. METHODS: We undertook a population-based serosurvey for SARS-CoV-2 infection in 26 subdistricts, Gauteng Province (population 15.9 million), South Africa, to estimate SARS-CoV-2 infection, infection fatality rate (IFR) triangulating seroprevalence, recorded COVID-19 deaths and excess-mortality data. We employed three-stage random household sampling with a selection probability proportional to the subdistrict size, stratifying the subdistrict census-sampling frame by housing type and then selecting households from selected clusters. The survey started on 4 November 2020, 8 weeks after the end of the first wave (SARS-CoV-2 nucleic acid amplification test positivity had declined to <10% for the first wave) and coincided with the peak of the second wave. The last sampling was performed on 22 January 2021, which was 9 weeks after the SARS-CoV-2 resurgence. Serum SARS-CoV-2 receptor-binding domain (RBD) immunoglobulin-G (IgG) was measured using a quantitative assay on the Luminex platform. RESULTS: From 6332 individuals in 3453 households, the overall RBD IgG seroprevalence was 19.1% [95% confidence interval (CI): 18.1-20.1%] and similar in children and adults. The seroprevalence varied from 5.5% to 43.2% across subdistricts. Conservatively, there were 2 897 120 (95% CI: 2 743 907-3 056 866) SARS-CoV-2 infections, yielding an infection rate of 19 090 per 100 000 until 9 January 2021, when 330 336 COVID-19 cases were recorded. The estimated IFR using recorded COVID-19 deaths (n = 8198) was 0.28% (95% CI: 0.27-0.30) and 0.67% (95% CI: 0.64-0.71) assuming 90% of modelled natural excess deaths were due to COVID-19 (n = 21 582). Notably, 53.8% (65/122) of individuals with previous self-reported confirmed SARS-CoV-2 infection were RBD IgG seronegative. CONCLUSIONS: The calculated number of SARS-CoV-2 infections was 7.8-fold greater than the recorded COVID-19 cases. The calculated SARS-CoV-2 IFR varied 2.39-fold when calculated using reported COVID-19 deaths (0.28%) compared with excess-mortality-derived COVID-19-attributable deaths (0.67%). Waning RBD IgG may have inadvertently underestimated the number of SARS-CoV-2 infections and conversely overestimated the mortality risk. Epidemic preparedness and response planning for future COVID-19 waves will need to consider the true magnitude of infections, paying close attention to excess-mortality trends rather than absolute reported COVID-19 deaths.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Mutevedzi PC, Kawonga M, Kwatra G, et al. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey. Int J Epidemiol. 2022. PMID: 34718591. doi:10.1093/ije/dyab217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。